2022
DOI: 10.3390/ijms232213829
|View full text |Cite
|
Sign up to set email alerts
|

Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis

Abstract: Changes in cytokine profiles and cytokine networks are known to be a hallmark of autoimmune diseases, including systemic lupus erythematosus (SLE) and multiple sclerosis (MS). However, cytokine profiles research studies are usually based on the analysis of a small number of cytokines and give conflicting results. In this work, we analyzed cytokine profiles of 41 analytes in patients with SLE and MS compared with healthy donors using multiplex immunoassay. The SLE group included treated patients, while the MS p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 72 publications
1
6
0
Order By: Relevance
“…This chemokine had been reported to communicate with CCR1, CCR4, and CCR5 receptors on target cells, the expression of CCL3 was elevated in pristine-induced model of SLE. 39 In addition, FISETIN was found to decrease expression of CCL3 and improve the condition of SLE in animal models. 40 CCL3 was also known as an inflammatory marker with differential expression among SLE subjects and other autoimmune diseases.…”
Section: Discussionmentioning
confidence: 99%
“…This chemokine had been reported to communicate with CCR1, CCR4, and CCR5 receptors on target cells, the expression of CCL3 was elevated in pristine-induced model of SLE. 39 In addition, FISETIN was found to decrease expression of CCL3 and improve the condition of SLE in animal models. 40 CCL3 was also known as an inflammatory marker with differential expression among SLE subjects and other autoimmune diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Some studies have identified increased expression of IL-1β in the serum of SLE patients ( 18 , 19 ) and in lupus-prone mouse models ( 20 ). Our data suggest that IL-1β is not critical for nephritis progression but may in fact have a protective effect that is revealed when its function is inhibited in isolation (as opposed to full inflammasome complex targeting).…”
Section: Discussionmentioning
confidence: 99%
“…It was reported that CCL3 participated in the in ammatory response by recruiting polymorphonuclear cells. This chemokine had been reported to communicate with CCR1, CCR4 and CCR5 receptors on target cells [46] , the expression of CCL3 was elevated in pristin-induced model of SLE [47] . In addition, FISETIN was found to decrease expression of CCL3 and improve the condition of SLE in animal models [48] .…”
Section: Discussionmentioning
confidence: 99%